Searched for
ANDREW WITTY
What happened to UnitedHealth CEO Andrew Witty, why has he stepped down? Here could be the reasonsAndrew Witty has stepped down as CEO of UnitedHealth for personal reasons. The company also withdrew its 2025 financial forecast due to ris...- Andrew Witty steps down as UnitedHealth Group CEO as company fights executive murder, rising costs, and stock crashUnitedHealth Group said CEO Andrew Witty is stepping down for “personal reasons” and suspended its 2025 forecast, sending shares of the hea...
- UnitedHealth CEO tells the employees company will continue to prevent unnecessary care, leaked internal video goes viral; trolls warn him he is next after Brian ThompsonUnitedHealth Group CEO Andrew Witty faced widespread backlash after an internal video was leaked, revealing his comments on the company’s p...
- Can pharma learn from auto? Of course!The drug industry is facing threats from unexpected rivals such as Google and Samsung, while the auto sector is grappling with new-age neme...
- Andrew Witty leaves GSK with new challenges, robust pipelineThe next wave of drug launches from an active pipeline of 25 clinical programmes will determine how strongly GSK charts its future growth.
- GSK names Emma Walmsley as CEO-designateWalmsley had joined GSK in 2010 from L'Oreal where, over the course of her 17-year career, she held marketing and management positions in t...
- Low sales of Horlicks in India partially offset GSK Healthcare's growthLow sales of Horlicks in India partially offset GlaxoSmithKline Healthcare’s good growth in most regions across the world in the quarter en...
- We will offer India new drugs at reasonable price: Andrew Witty, global CEO, GlaxoSmithKlineWitty talks about GSK’s India plans, the local IP laws and the debate on high pricing of drugs. Edited excerpts:
- ET GBS: India can create new, affordable healthcare systems, says GSK's Andrew WittyThe GSK chief said that globally the healthcare industry has achieved a lot in extending life expectancy but it has not succeeded in improv...
- ET GBS: UP looks to attract investments, explore business collaborations as part of development driveThe state’s young CM, Akhilesh Yadav, has been seeking to make UP a more attractive destination for investment and is trying to turn busine...
- ET GBS: Active lifestyle, sensible eating can keep India fit, says GlaxoSmithKline CEO Andrew WittyThe best way for any country to ensure the well-being of its people is to see that they follow an active lifestyle, eat sensibly and genera...
- GSK to invest Rs 864 crore to set up pharma unit in IndiaGlobal pharmaceutical major GlaxoSmithKline (GSK) today announced a Rs 864 crore investment in India to set up a medicine manufacturing uni...
- GlaxoSmithKline emerging markets head sent to handle China crisis: SourceGlaxoSmithKline has sent its head of emerging markets to China to lead the drugmaker's response to an unfolding crisis over alleged bribery...
- GSK open to acquiring reasonably priced company: GSK open to acquiring reasonably priced company: Andrew Witty, CEOWitty said that Cos need to find fresh solutions to tackle issues like affordability, access & escalating research costs
- Glaxo's growth is not an accident: Andrew Witty, global CEOAndrew Witty, global CEO of GlaxoSmithKline, is a self-confessed Indophile. He's run Glaxo's India operations for five years from 1999. Now...
- Glaxo to step up capacity for elephantiasis drug productionBritish drugmaker GlaxoSmithKline (GSK) will increase its capacity to make a drug for the treatment of elephantiasis at its manufacturing f...
- GSK to lower prices to woo India mktGlaxoSmithKline CEO Andrew Witty says the pharma major plans to invest Rs 430 crore to develop vaccines here.
- GSK to get 1 bn pound boost in 2010 due to swine flu medicineGlaxoSmithKline is likely to get 1 billion pound revenue boost in 2010, as governments stockpile swine flu medicines designed to combat a p...
- Glaxo to buy BMS Pakistan for $36.5 millionGlaxoSmithKline, the world's second biggest drugmaker, said that it was buying Bristol-Myers Squibb Pakistan for $36.5 million, adding to r...
- Glaxo's Viehbacher to leave after missing CEO jobChris Viehbacher, who lost out to Andrew Witty in the race to lead GlaxoSmithKline Plc is to leave the world's second largest drugmaker on ...
Load More
